236 related articles for article (PubMed ID: 36187110)
1. Ubiquitination-mediated molecular pathway alterations in human lung squamous cell carcinomas identified by quantitative ubiquitinomics.
Zhan X; Lu M; Yang L; Yang J; Zhan X; Zheng S; Guo Y; Li B; Wen S; Li J; Li N
Front Endocrinol (Lausanne); 2022; 13():970843. PubMed ID: 36187110
[TBL] [Abstract][Full Text] [Related]
2. Label-free quantitative identification of abnormally ubiquitinated proteins as useful biomarkers for human lung squamous cell carcinomas.
Lu M; Chen W; Zhuang W; Zhan X
EPMA J; 2020 Mar; 11(1):73-94. PubMed ID: 32140187
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitinomics revealed disease- and stage-specific patterns relevant for the 3PM approach in human sigmoid colon cancers.
Yang H; Li N; Chen L; Zhou L; Zhou Y; Liu J; Jia W; Chen R; Su J; Yang L; Gong X; Zhan X
EPMA J; 2023 Sep; 14(3):503-525. PubMed ID: 37605648
[TBL] [Abstract][Full Text] [Related]
4. mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy.
Zhao J; Zhai B; Gygi SP; Goldberg AL
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15790-7. PubMed ID: 26669439
[TBL] [Abstract][Full Text] [Related]
5. PTEN increases autophagy and inhibits the ubiquitin-proteasome pathway in glioma cells independently of its lipid phosphatase activity.
Errafiy R; Aguado C; Ghislat G; Esteve JM; Gil A; Loutfi M; Knecht E
PLoS One; 2013; 8(12):e83318. PubMed ID: 24349488
[TBL] [Abstract][Full Text] [Related]
6. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.
Trigka EA; Levidou G; Saetta AA; Chatziandreou I; Tomos P; Thalassinos N; Anastasiou N; Spartalis E; Kavantzas N; Patsouris E; Korkolopoulou P
Oncol Rep; 2013 Aug; 30(2):623-36. PubMed ID: 23728071
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
[TBL] [Abstract][Full Text] [Related]
8. Combination of artesunate and WNT974 induces KRAS protein degradation by upregulating E3 ligase ANACP2 and β-TrCP in the ubiquitin-proteasome pathway.
Gong RH; Chen M; Huang C; Wong HLX; Kwan HY; Bian Z
Cell Commun Signal; 2022 Mar; 20(1):34. PubMed ID: 35305671
[TBL] [Abstract][Full Text] [Related]
9. NEDD4-induced degradative ubiquitination of phosphatidylinositol 4-phosphate 5-kinase α and its implication in breast cancer cell proliferation.
Tran MH; Seo E; Min S; Nguyen QT; Choi J; Lee UJ; Hong SS; Kang H; Mansukhani A; Jou I; Lee SY
J Cell Mol Med; 2018 Sep; 22(9):4117-4129. PubMed ID: 29851245
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between HSPA5 arginylation and sequential ubiquitination leads to AKT degradation through autophagy flux.
Kim HJ; Kim SY; Kim DH; Park JS; Jeong SH; Choi YW; Kim CH
Autophagy; 2021 Apr; 17(4):961-979. PubMed ID: 32164484
[TBL] [Abstract][Full Text] [Related]
11. Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: an emerging treatment strategy for squamous cell lung carcinoma.
Beck JT; Ismail A; Tolomeo C
Cancer Treat Rev; 2014 Sep; 40(8):980-9. PubMed ID: 25037117
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of proteasome reveals basal mitochondrial ubiquitination.
Sulkshane P; Duek I; Ram J; Thakur A; Reis N; Ziv T; Glickman MH
J Proteomics; 2020 Oct; 229():103949. PubMed ID: 32882436
[TBL] [Abstract][Full Text] [Related]
13. A leucine-rich diet modulates the tumor-induced down-regulation of the MAPK/ERK and PI3K/Akt/mTOR signaling pathways and maintains the expression of the ubiquitin-proteasome pathway in the placental tissue of NMRI mice.
Viana LR; Gomes-Marcondes MC
Biol Reprod; 2015 Feb; 92(2):49. PubMed ID: 25395678
[TBL] [Abstract][Full Text] [Related]
14. Akt Phosphorylates Wnt Coactivator and Chromatin Effector Pygo2 at Serine 48 to Antagonize Its Ubiquitin/Proteasome-mediated Degradation.
Li Q; Li Y; Gu B; Fang L; Zhou P; Bao S; Huang L; Dai X
J Biol Chem; 2015 Aug; 290(35):21553-67. PubMed ID: 26170450
[TBL] [Abstract][Full Text] [Related]
15. Role of the ubiquitin-proteasome system in brain ischemia: friend or foe?
Caldeira MV; Salazar IL; Curcio M; Canzoniero LM; Duarte CB
Prog Neurobiol; 2014 Jan; 112():50-69. PubMed ID: 24157661
[TBL] [Abstract][Full Text] [Related]
16. Rhapontigenin inhibits TGF-β-mediated epithelial‑mesenchymal transition via the PI3K/AKT/mTOR pathway and is not associated with HIF-1α degradation.
Yeh YH; Wang SW; Yeh YC; Hsiao HF; Li TK
Oncol Rep; 2016 May; 35(5):2887-95. PubMed ID: 26986649
[TBL] [Abstract][Full Text] [Related]
17. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitination and the ubiquitin - proteasome system in the pathogenesis and treatment of squamous head and neck carcinoma.
Voutsadakis IA
Anticancer Res; 2013 Sep; 33(9):3527-41. PubMed ID: 24023278
[TBL] [Abstract][Full Text] [Related]
19. The Roles of Ubiquitin in Mediating Autophagy.
Yin Z; Popelka H; Lei Y; Yang Y; Klionsky DJ
Cells; 2020 Sep; 9(9):. PubMed ID: 32887506
[TBL] [Abstract][Full Text] [Related]
20. The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer.
Ye Z; Yang J; Jiang H; Zhan X
Front Endocrinol (Lausanne); 2023; 14():1220108. PubMed ID: 37795365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
